SynthesisBMC cardiovascular disorders2026

Inclisiran SiRNA therapy for durable LDL-C reduction: a systematic review and meta-analysis highlighting a breakthrough in long-term cardiovascular risk management.

Shakta Mani Satyam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.